The role of ARID1A in cancer is exercised by the involvement in EZH2 methyltransferase activity, the PI3K/AKT/mTOR pathway, the regulation of p53 targets, DNA damage checkpoints, and the tumor immune response [48]. This evidence concerns the gene ARID1A and cancer.